Rhythm Pharmaceuticals, Inc. (RYTM)
103.10
+2.39
(+2.37%)
USD |
NASDAQ |
Dec 10, 12:10
Rhythm Pharmaceuticals EPS Diluted (Quarterly): -0.8192 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 2.434 |
| Terns Pharmaceuticals, Inc. | -0.2686 |
| Altimmune, Inc. | -0.2126 |
| Viking Therapeutics, Inc. | -0.8083 |
| Cidara Therapeutics, Inc. | -3.096 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -52.90M |
| Revenue (Quarterly) | 51.30M |
| Total Expenses (Quarterly) | 104.20M |
| Enterprise Value | 6.565B |
| Gross Profit Margin (Quarterly) | 89.08% |
| Profit Margin (Quarterly) | -103.1% |
| Earnings Yield | -3.01% |
| Normalized Earnings Yield | -3.000 |